Asunto(s)
Enfermedades Fetales/diagnóstico por imagen , Imagenología Tridimensional , Neoplasias del Mediastino/diagnóstico por imagen , Teratoma/diagnóstico por imagen , Ultrasonografía Prenatal , Adulto , Femenino , Enfermedades Fetales/cirugía , Humanos , Neoplasias del Mediastino/complicaciones , Neoplasias del Mediastino/cirugía , Polihidramnios/etiología , Embarazo , Teratoma/complicaciones , Teratoma/cirugíaRESUMEN
117 women with severe pelvic organ prolapse (POP; stage > 2) were enrolled to elucidate a 24-month outcome of POP surgery, using conventional or mesh repair with 3 techniques. 59 patients underwent conventional repair and 58 underwent mesh repair. Two types of mesh were used: a trocar-guided transobturator polypropylene (Avaulta, Bard Inc.) and a porcine dermis mesh (Pelvisoft, Bard Inc.). Women with recurrences, who underwent previous unsuccessful conventional repair, were randomised. Primary outcome was the evaluation of anatomic failures (prolapse stage > 1) in treated and untreated compartments. Anatomic failure was observed in 11 of 58 patients (19%; CI 8.9-29) in the mesh group and in 16 of 59 patients (27.1%; p value = 0.3) in the conventional group. 9 of 11 failures in the mesh group (15.5%; CI 6.2-24.8) were observed in the untreated compartment (de novo recurrences), 14.3% in Pelvisoft and 16.7% in Avaulta arm, while only 1 recurrence in the untreated compartment (1.7%) was observed in the conventional group (odds ratio 10.6, p = 0.03).
Asunto(s)
Procedimientos Quirúrgicos Ginecológicos/instrumentación , Prolapso de Órgano Pélvico/cirugía , Anciano , Femenino , Humanos , Persona de Mediana Edad , Recurrencia , Mallas QuirúrgicasAsunto(s)
Hemangioma/diagnóstico , Complicaciones Neoplásicas del Embarazo/diagnóstico , Compresión de la Médula Espinal/diagnóstico , Neoplasias de la Médula Espinal/diagnóstico , Enfermedad Aguda , Adulto , Femenino , Hemangioma/patología , Humanos , Imagen por Resonancia Magnética , Embarazo , Complicaciones Neoplásicas del Embarazo/patología , Tercer Trimestre del Embarazo , Compresión de la Médula Espinal/patología , Neoplasias de la Médula Espinal/patologíaRESUMEN
We report the efficacy of a minimally invasive approach of the multidose protocol with methotrexate (MTX) in the management of three cases of interstitial pregnancy (IP), with elevated serum ß-hCG in two cases. New considerations and management strategies are discussed. Successful termination of IP and in one case, a subsequent successful pregnancy, was achieved. The process led to the development of an enhanced understanding of diagnostic modalities and their limitations, with regard to the particular entities under discussion. We also focused attention on pivotal points and anatomical features in the management of this dangerous occurrence. Long-term results with careful follow-up were analysed by instrumental procedure. This hazardous type of ectopic pregnancy can be managed with systemic administration of MTX, also in patients with elevated ß-hCG values. The present report underlines that an integrated approach in early diagnosis, multidose treatment and close follow-up, are essential forms of medical management.
Asunto(s)
Abortivos no Esteroideos/uso terapéutico , Metotrexato/uso terapéutico , Embarazo Ectópico/tratamiento farmacológico , Adulto , Femenino , Humanos , EmbarazoRESUMEN
In 153 consecutive patients with cirrhosis we assessed: (1) the prevalence of IgG to Helicobacter pylori and compared it with that found in 1010 blood donors resident in the same area; and (2) the relationships of IgG to Helicobacter pylori with clinical and endoscopic features and with the risk of peptic ulcer. The IgG to Helicobacter pylori prevalence of cirrhotics was significantly higher than in blood donors (76.5% vs 41.8%; P < 0.0005) and was not associated with sex, cirrhosis etiology, Child class, gammaglobulins and hypertensive gastropathy. In both groups, the prevalence of IgG to Helicobacter pylori was significantly higher in subjects over 40. Among patients with cirrhosis a significantly higher prevalence of Helicobacter pylori was found in patients with previous hospital admission (P = 0.02) and/or upper gastrointestinal endoscopy (P = 0.01) and patients with peptic ulcer (P = 0.0004). Multivariate analysis identified increasing age and male sex as risk factors for a positive Helicobacter pylori serology and no independent risk factors for peptic ulcer. The high prevalence of Helicobacter pylori-positive serology found in the present series is related to age and sex and might also be explained by previous hospital admissions and/or upper gastrointestinal endoscopy. Our results do not confirm the role of Helicobacter pylori as risk factor for peptic ulcer in patients with liver cirrhosis.
Asunto(s)
Infecciones por Helicobacter/epidemiología , Helicobacter pylori , Cirrosis Hepática/epidemiología , Úlcera Péptica/epidemiología , Adulto , Distribución por Edad , Anciano , Anticuerpos Antibacterianos/sangre , Distribución de Chi-Cuadrado , Endoscopía Gastrointestinal/estadística & datos numéricos , Femenino , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/inmunología , Helicobacter pylori/inmunología , Humanos , Inmunoglobulina G/sangre , Italia/epidemiología , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/inmunología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Úlcera Péptica/diagnóstico , Úlcera Péptica/inmunología , Prevalencia , Factores de Riesgo , Estudios Seroepidemiológicos , Distribución por SexoRESUMEN
AIM: It has been showed that peptic ulcer is more frequent in patients with liver cirrhosis, is associated with the severity of cirrhosis, and occurs without upper abdominal pain in up to 70% of patients and with complications in 29%. The aim of this study was to retrospectively assess the characteristics of peptic ulcer in a large series of patients with liver cirrhosis. MATERIALS AND METHODS: In this retrospective study the consecutive records of 1,748 endoscopies, performed in patients with liver cirrhosis during a period of 14 years, were reviewed to evaluate the frequency and clinical characteristics of peptic ulcer. RESULTS: The ulcer prevalence was 6.3%, and 77.5% of the ulcers were asymptomatic. Complications from ulcer were present in 29% of all patients and in 32% of those who has the first diagnosis of ulcer during the study. Patients with asymptomatic ulcer had a more decompensated cirrhosis. After healing, 20%-25% of the recurrent ulcers had complications while patients were on standard maintenance treatment. CONCLUSIONS: This retrospective study confirms the high frequency of peptic ulcer in patients with liver cirrhosis. It also confirms that the peptic ulcer in these patients is very often asymptomatic and associated with concurrent complications, especially in those with more severe liver disease. The complication rate in recurrent ulcers was 20%-25%. However, due to the retrospective nature of this study, after ulcer healing the endoscopic follow-up was irregular. Regularly repeated endoscopy should be carried out in patients with liver cirrhosis and peptic ulcer to diagnose new and recurrent ulcers and to prevent related complications.
Asunto(s)
Cirrosis Hepática/complicaciones , Úlcera Péptica/complicaciones , Femenino , Humanos , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/fisiopatología , Masculino , Persona de Mediana Edad , Úlcera Péptica/diagnóstico , Recurrencia , Estudios RetrospectivosRESUMEN
OBJECTIVE: To assess the effects of chronic oral administration of standard doses of lansoprazole on the luteinizing hormone pulsatile pattern and on follicle stimulating hormone (FSH) and testosterone levels in young men. DESIGN AND METHODS: Eleven healthy volunteers were studied on three separate occasions, before and after two 3-week periods of treatment with lansoprazole (30 mg every morning) or a placebo, according to a randomized, double-blind, double-dummy, cross-over design. On each study day, blood samples were taken every 15 min for 8 h. The pulsatile pattern of luteinizing hormone, mean concentrations of FSH and total testosterone plasma levels were determined for each patient using specific radioimmunoassays. RESULTS: Lansoprazole did not significantly affect mean plasma levels, the pulsatile pattern of luteinizing hormone, or mean plasma concentrations of FSH and testosterone compared with the placebo. CONCLUSIONS: This study indicates that chronic oral administration of standard doses of lansoprazole does not affect the concentrations of gonadal hypothalamic pituitary or sex steroid hormones.
Asunto(s)
Antiulcerosos/farmacología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Omeprazol/análogos & derivados , Testículo/efectos de los fármacos , 2-Piridinilmetilsulfinilbencimidazoles , Administración Oral , Adulto , Estudios Cruzados , Método Doble Ciego , Hormona Folículo Estimulante/sangre , Humanos , Lansoprazol , Hormona Luteinizante/sangre , Masculino , Omeprazol/administración & dosificación , Omeprazol/farmacología , Radioinmunoensayo , Testosterona/sangreRESUMEN
1. The pharmacokinetics of feprazone have been studied in 10 patients with rheumatoid arthritis (RA), and in a further six patients with renal impairment (RI) who were not suffering from rheumatoid disease. 2. For RA patients, the mean elimination half-life (t1/2) of feprazone after a single oral dose was 21 +/- 5 h (SD), the mean apparent clearance (Cl) was 0.012 +/- 0.009 l/h per kg, and the mean apparent volume of distribution (Vd) was 0.33 +/- 0.17 l/kg. Corresponding values for RI patients were 25 +/- 13 h, 0.016 +/- 0.011 l/h per kg, and 0.46 +/- 0.24 l/kg, respectively. 3. These results show no impairment of the elimination of feprazone in RA or RI patients; Vd and Cl are greater than in healthy young volunteers or elderly subjects, the AUC values are lower, but t1/2 values are similar in all groups. 4. It is suggested that the greater Cl and Vd, and lower AUC, in RA and RI patients may be due to renal insufficiency and decreased plasma protein binding of feprazone and its metabolite, or to induction of glucuronyl transferase activity by the prior medication, thus enhancing the formation of the major metabolite, the C(4)-glucuronide, and increasing drug elimination.
Asunto(s)
Artritis Reumatoide/metabolismo , Feprazona/farmacocinética , Enfermedades Renales/metabolismo , Administración Oral , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Feprazona/administración & dosificación , Humanos , Masculino , Tasa de Depuración Metabólica , Persona de Mediana EdadRESUMEN
The spoiling of coagulation factors, proteic patterns and specific activity has been comparatively determined in fresh frozen plasma, cryoprecipitates and hemodiagnostic sera, thawed in a 37 degrees C water bath and in a microwave oven. Effects of conventional and microwave heating are not significantly different, while results of the latter technique are rapid and aseptic. Previously, heating performances of a commercial microwave oven have been investigated for deionized water, saline solutions, and bovine serum. Furthermore, plastic containers of hemoderivatives have been tested to assure that no toxic products are released during microwave heating.
Asunto(s)
Conservación de la Sangre , Calor , Microondas , Sistema del Grupo Sanguíneo ABO , Adulto , Factores de Coagulación Sanguínea , Femenino , Congelación , Humanos , MasculinoAsunto(s)
Benzodiazepinonas/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Duodenitis/tratamiento farmacológico , Gastritis/tratamiento farmacológico , Parasimpatolíticos/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Adulto , Benzodiazepinonas/efectos adversos , Carbenoxolona/uso terapéutico , Cimetidina/uso terapéutico , Ensayos Clínicos como Asunto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Morfolinas/uso terapéutico , Parasimpatolíticos/efectos adversos , Pirenzepina , Proglumida/uso terapéutico , Piridinas/uso terapéutico , Sialoglicoproteínas/uso terapéuticoRESUMEN
The main pharmacodynamic characteristics of pirenzepine are briefly reported and the experimental plan of the clinical trial on pirenzepine in peptic ulcer is discussed.
Asunto(s)
Antiulcerosos/uso terapéutico , Benzodiazepinonas/uso terapéutico , Piperazinas/uso terapéutico , Atropina/uso terapéutico , Ensayos Clínicos como Asunto , Humanos , Úlcera Péptica/tratamiento farmacológico , PirenzepinaRESUMEN
A device operated by compression has been studied in order to define a method of measuring analgesic effects. Three analgesics (metamizol, acetylsalicylic acid and ketobemidone) and placebo have been tested in man to verify the adequacy of this apparatus and its sensitivity.